Document is current
Any future updates will be listed below
-
Authors
Goldschmidt, Valentina
Apodaca, Elia Ixel
Gálvez, Kenny Mauricio
Wannesson, Bruno
Scheinberg, Phillip
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 22 August 2024
First Online: 5 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: Valentina Goldschmidt has received honoraria for consulting services and academic activities from Bristol Myers Squibb; funding for conference attendance from AstraZeneca; has engaged in speaker and academic activities with Takeda. Elia Ixel Apodaca has received honoraria from AbbVie, Asofarma, AstraZeneca, and Bristol Myers Squibb. Kenny Mauricio Gálvez declares no conflicts of interest.Bruno Wannesson has received honoraria for academic lectures from AstraZeneca, Nolter, Pint Pharma, Raffo, Terumo BCT, and Therakos; and for participation in advisory boards from AstraZeneca and Pint Pharma. Phillip Scheinberg declares no conflicts of interest.
